GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 1 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $23,000 | -54.9% | 63,151 | 0.0% | 0.00% | – |
| Q2 2019 | $51,000 | -26.1% | 63,151 | +5.0% | 0.00% | – |
| Q1 2019 | $69,000 | -25.0% | 60,168 | -50.0% | 0.00% | – |
| Q4 2018 | $92,000 | -25.2% | 120,336 | +100.0% | 0.00% | – |
| Q3 2018 | $123,000 | -79.9% | 60,168 | 0.0% | 0.00% | – |
| Q2 2018 | $613,000 | +102.3% | 60,168 | +28.9% | 0.00% | – |
| Q1 2018 | $303,000 | +7.4% | 46,669 | +31.5% | 0.00% | – |
| Q4 2017 | $282,000 | -15.8% | 35,491 | 0.0% | 0.00% | – |
| Q3 2017 | $335,000 | – | 35,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
| Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
| DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
| HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
| Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
| NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
| SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
| Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
| Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |